Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
clinical trials
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
medical devices
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
What
patients
3
×
drug
market
advantages
analytics
bar
bio
biofourmis
brings
cancer
data
devices
digital
eisai
employs
expect
fda
flags
gamble
globally
hauls
help
higher
incidence
lorcaserin
loss
marketing
medco’s
medicine
million
mover
new
payers
physicians
plan
post
pricing
pulls
raised
risks
Language
unset
3
×
Current search:
patients
×
" boston top stories "
×
unset
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
